期刊文献+

有效抗病毒治疗后感染CXCR4 CCR5嗜性病毒的HIV感染者细胞内残留病毒的比较 被引量:2

A comparative study of intracellular residual viruses in different HIV tropism patients after effective antiviral therapy
原文传递
导出
摘要 目的探讨抗病毒治疗(ART)后病毒载量稳定在检测限以下的艾滋病病毒(HIV)感染者辅助受体使用与HIV库之间的关系。方法通过病毒env-脱氧核糖核酸(DNA)测序和geno2pheno预测HIV辅助受体的使用是CCR5还是CXCR4,用广州海力特生物科技有限公司试剂盒检测血液中的HIV DNA及未剪切的HIV核糖核酸(RNA)(usRNA)。结果共收集67例HIV感染者,CCR5嗜性感染者37例,CXCR4嗜性感染者30例。CXCR4嗜性的HIV DNA水平为(3.435±0.587)拷贝/106外周血单个核细胞(PBMC),CCR5嗜性为(2.938±0.664)拷贝/106 PBMC,两者差异有统计学意义(P<0.01);CXCR4嗜性的usRNA水平为(3.714±0.448)拷贝/106 PBMC,CCR5嗜性为(3.122±0.611)拷贝/10^6 PBMC,两者差异有统计学意义(P<0.001)。结论 CXCR4嗜性病毒和较高的HIV库相关。 Objective To investigate the relationship between the use co-receptor and HIV reservoir in patients with stable viral load below the detection line after ART. Methods A total of 67 patients were enrolled. Virus env-DNA sequencing and geno2 pheno were used to predict CCR5 or CXCR4 co-receptor used. HIV in 37 patients used CCR5 co-receptor and 30 patients used CXCR4 co-receptor. The HIVDNA and un-spliced HIV RNA(usRNA) in blood were detected with the kit of Guangzhou Hailite Biotechnology Co.,Ltd. Results In cases of CXCR4 patients, the level of HIVDNA was significantly higher than that in CCR5,with an average of(3.435±0.587)and(2.938±0.664)copies/10^6 respectively(P<0.01). The level of usRNA in CXCR4 patients was significantly higher than that in CCR5, with an average of(3.714±0.448) and(3.122±0.611) respectively(P<0.001). Conclusion CXCR4 tropic viruses are associated with higher HIV reservior.
作者 张海红 姜海晶 何焱玲 ZHANG Haihong;JIANG Haijing;HE Yanling(Beijing Huatrou Hospital,Beijing 101400,China;Beijing Chaoyang Hospital,Capital Medical University,Beijing 100020)
出处 《中国艾滋病性病》 CAS CSCD 北大核心 2019年第12期1215-1217,共3页 Chinese Journal of Aids & STD
基金 国家科技重大专项(2015ZX10004801-002-002) 国家自然科学基金(81371803)。
  • 相关文献

参考文献1

二级参考文献17

  • 1Zhou HY, Zheng YH, Zhang CY, et al. Evaluation of human immunodeficiency virus type 1-infected Chinese patients treated with highly activeantiretroviral therapy for two years [J]. Viral Immunol, 2007, 20(1): 180-187.
  • 2He M, Zheng YH, Zhou HY, et al. Prospective observation for seven- year's highly active antiretroviral therapy in Chinese HIV-1 infected patients[J]. Curr H1V Res, 2011, 9(3): 160-165.
  • 3Marcello A. Latency: the hidden HIV-1 challenge[J]. Retrovirolog)5 2006, 3: 7.
  • 4Blankson JN, Siliciano JD, Siliciano RF. "l'he Effect of early treatment on the latent reservoir of HIV-I[J].J Infect Dis, 2005, 191(9): 1394- 1396.
  • 5Cheney KM, Kumar R, Purins A, et al. HIV type 1 persistence in CD4-/CD8- double negative T cells from patients on antiretroviral therapy[J]. AIDS Res Hum Retroviruses, 2006, 22(1): 66-75.
  • 6Finzi D, Blankson J, Siliciano JD, et al. Latent infection of CD4: T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy[J]. Nat Med, 1999, 5(5): 512-517.
  • 7Re MC, Vitone F, Biagetti C, et al. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients[J]. Clin Microbiol Infect, 2010, 16(6): 640-646.
  • 8Gibellini D, Borderi M, De Crignis E, et al. H1V- 1 DNA load analysis in peripheral blood lymphocytes and monocytes from naive and HAAT- treated individuals [J]. J Infect, 2008, 56 (3): 219-225.
  • 9Shiramizu B, Ananworanich J, Chalermchai T, et al. Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testingimpairment after first-line combined antiretroviral therapy[J]. J Neurovirol, 2012, 18(I): 69-73.
  • 10Sun JC, Beilke JN, Lanier LL. Immune memory redefined: characterizing the longevity of natural killer cells[J]. Immunol Rev, 2010, 236: 83-94.

共引文献7

同被引文献29

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部